The Covid-19 pandemic has created urgent demand for health innovations to better serve individuals, organisations and entire societies. The pharmaceutical industry has been on the frontlines of the challenge as it races against time to find solutions.
The development of coronavirus vaccines in a matter of months is an achievement that few would have thought possible. The fact that it happened demonstrates the resilience of the sector and its ability to harness research talent to meet urgent challenges.
With production now up and running, the next challenge is distribution and actually getting the shots into people’s arms. This presents a new set of challenges for the public-sector side of the healthcare system.
Pharmaceutical companies have also been learning on the fly about how to manage complex supply chains and new models for…
